Back to the solutions

Our first solution combining DNA and protein analysis from a solid tumour sample.

The most cost-effective solution designed to fit in your routine practice.

Order an OncoDEEP

I am a patient

See how OncoDEEP helped Christine in the treatment of her breast cancer.

View Christine's report

OncoDEEP Solution

OncoDEEP was the first solution developed by OncoDNA (2013). It includes the sequencing of 75 genes linked to approved targeted therapies. This panel of genes is based on an accurate analysis of the oncologists’ needs in their current practice when the choice of solutions is reduced for the patients. This panel is updated every year based on the evolution of the literature, to provide the patients the most cost-effective solution.

Description

OncoDEEP was the first solution developed by OncoDNA (2013). It includes the sequencing of 75 genes linked to approved targeted therapies. This panel of genes is based on an accurate analysis of the oncologists’ needs in their current practice when the choice of solutions is reduced for the patients. This panel is updated every year based on the evolution of the literature, to provide the patients the most cost-effective solution.

Beside the sequencing analysis which has been shown to only reveal partially the identity of the tumour, we perform additional analyses giving critical and non-redundant information using technologies like IHC, or by looking at microsatellite instability, unusual and damaging splicing mRNA or methylation of genes. Through this unique and integrated approach OncoDEEP establishes a complete genetic profile of the tumour which can be used to identify response to targeted therapies but also to classical chemotherapies and or novel immunotherapies.

Advantages

OncoDEEP is designed to be used when therapeutic ambiguities exist in adult patients with solid tumors:

  • Multiple treatment options for standard therapies
  • Standard options cannot be considered due to comorbidities
  • Standards of care have been exhausted
  • Highly aggressive cancers
  • Rare or less frequent tumors

How much does OncoDEEP cost ?

Suggested price

2990 Eur

Country-specific price differences

The price indicated here is the recommended retail price. This price might vary in your country, depending on different factors like importation fees, freight costs, currency exchange rate, …
For more info or to order this product in your region, please contact our local representative.

Reimbursement statement

Currently our tests are reimbursed in a growing number of countries. In the United Kingdom, OncoSTRAT&GO is reimbursed for patients insured by BUPA Global Insurance, using code 7331B. Other countries, like Spain, Chili, South Africa or Poland, are also covering totally or partially the cost of our tests. Don’t hesitate to contact us for more information.

How to get OncoDEEP?

Ordering a solution is very simple: just log into OncoSHARE, select your solution(s) and pay. If you don’t have a kit, we’ll send you one.

The case report

Alicia, 49 years old when diagnosed

Was given the OncoDEEP solution following a stage 3 lung cancer.

View Alicia's report